CLINICAL_TRIALS ClinicalTrials.gov record update

A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study to Assess the LDL Cholesterol Lowering and Anti-Hyperglycemic Efficacy of Welchol® (Colesevelam) in Subjects With Impaired Fasting Glucose Who Are Taking Niaspan® (Niacin) for Dyslipidemia

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01239004
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:14.367612+00:00
Published At: 2012-01-06T00:00:00+00:00
Record Updated At: 2012-01-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Dyslipidemia", "Hyperlipidemia", "Hyperglycemia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-01-06"
protocolSection.identificationModule.nctId: "NCT01239004"
protocolSection.identificationModule.officialTitle: "A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study to Assess the LDL Cholesterol Lowering and Anti-Hyperglycemic Efficacy of Welchol\u00ae (Colesevelam) in Subjects With Impaired Fasting Glucose Who Are Taking Niaspan\u00ae (Niacin) for Dyslipidemia"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.